Items Tagged ‘bosutinib’

January 14, 2018

FDA Grants Accelerated Approval to Bosulif for Treatment of Newly-Diagnosed Chronic Myelogenous Leukemia


CancerConnect News: On December 19, 2017, the Food and Drug Administration granted accelerated approval to bosutinib Bosulif (bosutinib) for treatment of patients with newly-diagnosed chronic phase (CP) Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). ABOUT CHRONIC MYELOGENOUS LEUKEMIA (CML) Chronic myelogenous leukemia (CML) is a rare blood cancer, which begins in the bone marrow, […]

View full entry

Tags: (Ph+), Bosulif, bosutinib, chronic myelogenous leukemia, Chronic Myeloid Leukemia, chronic phase, CML, Gleevec, Leukemia, News, Philadelphia chromosome positive